title: ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing.
abstract: Autosomal dominant vitreoretinochoroidopathy (ADVIRC), a retinal dystrophy often associated with glaucoma and cataract, forms part of a phenotypic spectrum of 'bestrophinopathies'. It has been shown previously that ADVIRC results from BEST1 mutations that cause exon skipping and lead to the production of shortened and internally deleted isoforms. This study describes a novel ADVIRC mutation and show that it disrupts an exonic splice enhancer (ESE) site, altering the binding of a splicing-associated SR protein. As with previous ADVIRC mutations, the novel c.704T-->C mutation in exon 6 altered normal splicing in an ex vivo splicing assay. Both this and another exon 6 ADVIRC-causing mutation (c.707G-->A) either weakened or abolished splicing in an ESE-dependent splice assay compared with a nearby exon 6 mutation associated with Best disease (c.703G-->C). Gel shift assays were undertaken with RNA oligonucleotides encompassing the ADVIRC and Best disease mutations with four of the most commonly investigated SR proteins. Although SC35, SRp40 and SRp55 proteins all bound to the wild-type and mutated sequences with similar intensities, there was increased binding of ASF/SF2 to the two ADVIRC-mutated sequences compared with the wild-type or Best disease-mutated sequences. The exon skipping seen for these two exon 6 ADVIRC mutations and their affinity for ASF/SF2 suggests that the region encompassing these mutations may form part of a CERES (composite exonic regulatory elements of splicing) site.
authors.forename: R
authors.initials: R
authors.lastname: Burgess
authors.forename: R E
authors.initials: RE
authors.lastname: MacLaren
authors.forename: A E
authors.initials: AE
authors.lastname: Davidson
authors.forename: J E
authors.initials: JE
authors.lastname: Urquhart
authors.forename: G E
authors.initials: GE
authors.lastname: Holder
authors.forename: A G
authors.initials: AG
authors.lastname: Robson
authors.forename: A T
authors.initials: AT
authors.lastname: Moore
authors.forename: R O'
authors.initials: RO
authors.lastname: Keefe
authors.forename: G C M
authors.initials: GC
authors.lastname: Black
authors.forename: F D C
authors.initials: FD
authors.lastname: Manson
mesh_terms: D000328:Adult; D001483:Base Sequence; D000075002:Bestrophins; D018118:Chloride Channels / Q000235:genetics* / Q000378:metabolism; D015862:Choroid Diseases / Q000235:genetics* / Q000378:metabolism; D005091:Exons; D005136:Eye Proteins / Q000235:genetics* / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009154:Mutation; D010375:Pedigree; D011485:Protein Binding; D012326:RNA Splicing / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics; D012164:Retinal Diseases / Q000235:genetics* / Q000378:metabolism; D016415:Sequence Alignment
chemical_list: C113133:BEST1 protein, human; D000075002:Bestrophins; D018118:Chloride Channels; D005136:Eye Proteins; D012333:RNA, Messenger